Trial of Vemurafenib With or Without Bevacizumab in Patients With Stage IV BRAFV600 Mutant Melanoma
 
Sponsors and Collaborators
Melanoma Research Foundation Breakthrough Consortium
Genentech
 
Contact
Michael B Atkins, MD
617-632-9250
 
F. Stephen Hodi, MD
617-632-5053
 
Investigator
Michael B Atkins, MD
Beth Israel Deaconess Medical Center
 
F. Stephen Hodi, MD
Dana-Farber Cancer Institute
 
ClinicalTrials.gov Identifier